The pharmaceutical industry has long been criticized for its approach to chronic disease management. Peter Rost, a former Pfizer executive, revealed that the real focus is not on curing diseases, but on creating lifelong markets for drugs. The truth is that chronic diseases, which require ongoing medication, are far more profitable for drug companies than curing the condition.
Many chronic illnesses, such as diabetes, heart disease, and obesity, are largely preventable with lifestyle changes, yet the healthcare system often focuses on symptom management rather than finding cures. This has led to a pharmaceutical monopoly, where companies profit from keeping patients dependent on their medications.
Understanding this truth about big pharma can help us make better health decisions. Prevention, rather than long-term medication, should be a priority for healthcare. It’s time to take control of our health and make informed choices.